BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8303624)

  • 1. Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects.
    Dahlén B; Margolskee DJ; Zetterström O; Dahlén SE
    Thorax; 1993 Dec; 48(12):1205-10. PubMed ID: 8303624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma.
    Gaddy JN; Margolskee DJ; Bush RK; Williams VC; Busse WW
    Am Rev Respir Dis; 1992 Aug; 146(2):358-63. PubMed ID: 1489125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics.
    Dahlén B; Kumlin M; Margolskee DJ; Larsson C; Blomqvist H; Williams VC; Zetterström O; Dahlén SE
    Eur Respir J; 1993 Jul; 6(7):1018-26. PubMed ID: 8396534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.
    Dahlén B; Nizankowska E; Szczeklik A; Zetterström O; Bochenek G; Kumlin M; Mastalerz L; Pinis G; Swanson LJ; Boodhoo TI; Wright S; Dubé LM; Dahlén SE
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1187-94. PubMed ID: 9563738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilator properties of an inhaled leukotriene D4 antagonist (verlukast--MK-0679) in asthmatic patients.
    Lammers JW; Van Daele P; Van den Elshout FM; Decramer M; Buntinx A; De Lepeleire I; Friedman B
    Pulm Pharmacol; 1992 Jun; 5(2):121-5. PubMed ID: 1611229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human.
    Kips JC; Joos GF; De Lepeleire I; Margolskee DJ; Buntinx A; Pauwels RA; Van der Straeten ME
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):617-21. PubMed ID: 1892302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
    Diamant Z; Timmers MC; van der Veen H; Friedman BS; De Smet M; Depré M; Hilliard D; Bel EH; Sterk PJ
    J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma.
    Christie PE; Smith CM; Lee TH
    Am Rev Respir Dis; 1991 Oct; 144(4):957-8. PubMed ID: 1928974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airway responsiveness to leukotriene C4 (LTC4), leukotriene E4 (LTE4) and histamine in aspirin-sensitive asthmatic subjects.
    Christie PE; Schmitz-Schumann M; Spur BW; Lee TH
    Eur Respir J; 1993 Nov; 6(10):1468-73. PubMed ID: 8112440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids.
    Reiss TF; Sorkness CA; Stricker W; Botto A; Busse WW; Kundu S; Zhang J
    Thorax; 1997 Jan; 52(1):45-8. PubMed ID: 9039239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
    Hamilton AL; Watson RM; Wyile G; O'Byrne PM
    Thorax; 1997 Apr; 52(4):348-54. PubMed ID: 9196518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute bronchodilation with an intravenously administered leukotriene D4 antagonist, MK-679.
    Impens N; Reiss TF; Teahan JA; Desmet M; Rossing TH; Shingo S; Zhang J; Schandevyl W; Verbesselt R; Dupont AG
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1442-6. PubMed ID: 8389106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.
    Manning PJ; Watson RM; Margolskee DJ; Williams VC; Schwartz JI; O'Byrne PM
    N Engl J Med; 1990 Dec; 323(25):1736-9. PubMed ID: 2174121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
    Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.
    Margolskee DJ
    Ann N Y Acad Sci; 1991; 629():148-56. PubMed ID: 1659276
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of novel leukotriene--based anti-asthma drugs: MK-886 and MK-571.
    Young RN
    Agents Actions Suppl; 1991; 34():179-87. PubMed ID: 1793062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist.
    Mastalerz L; Nizankowska E; Sanak M; Mejza F; Pierzchalska M; Bazan-Socha S; Bestynska-Krypel A; Cmiel A; Szczeklik A
    Eur J Clin Invest; 2002 Dec; 32(12):949-55. PubMed ID: 12534456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of RG 12525, an oral leukotriene D4 antagonist, on the airway response to inhaled leukotriene D4 in subjects with mild asthma.
    Wahedna I; Wisniewski AS; Tattersfield AE
    Br J Clin Pharmacol; 1991 Oct; 32(4):512-5. PubMed ID: 1958449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.